BotVax B (Canada)

Clostridium botulinum Type B Toxoid

Purified botulinum type B toxoid aluminum phosphate adsorbed. Preservative: 0.01% Thimerosal. Contains no more than 1.85 g/L of formaldehyde as inactivating solution.

BotVax B Indications

BotVax^® B is for the prevention of equine botulism due to Clostridium botulinum Type B in healthy horses.

DOSAGE: Inject 2.0 mL intramuscularly at monthly intervals for a total of 3 doses. Booster annually with a single 2.0 mL intramuscular dose.

Research has demonstrated that pregnant mares immunized during the third trimester of gestation, with the third dose (booster) given 2-4 weeks before parturition, respond with antibody. This antibody is concentrated in colostrum and results in significant passively acquired antibody in normal sulking foals.

ADMINISTRATION: Inject intramuscularly using aseptic technique. Shake well before use.

CAUTIONS: Transitory local reactions at the injection site such as heat and minor swelling may occur. Anaphylactoid reactions may occur. Epinephrine is antidotal. Store at 2°-7°C (35°-45°F). Do not freeze. Use the entire contents when opened. Do not vaccinate food producing animals within 21 days of slaughter.

FOR VETERINARY USE ONLY

U.S. Vet. Lic. No. 302

Neogen Corporation, Lansing, MI 48912

800/525-2022

CPN: 12210013